We are live on ! Find out more
VFA

Values First Advisors Portfolio holdings

AUM $192M
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
AUM
$184M
AUM Growth
+$12.1M
Cap. Flow
+$761K
Cap. Flow %
0.41%
Top 10 Hldgs %
28.42%
Holding
196
New
14
Increased
88
Reduced
73
Closed
15

Top Buys

Rank Stock Value
1
ROL icon
Rollins
ROL
+$1.72M
2
MCHP icon
Microchip Technology
MCHP
+$977K
3
GNTX icon
Gentex
GNTX
+$639K
4
CGNX icon
Cognex
CGNX
+$570K
5
CHWY icon
Chewy
CHWY
+$555K

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 15.61%
3 Industrials 10.9%
4 Consumer Discretionary 7.42%
5 Real Estate 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
76
DELISTED
Blueprint Medicines
BPMC
$729K 0.4%
5,685
+652
+13% +$67.7K
OHI icon
77
Omega Healthcare
OHI
$15.4B
$721K 0.39%
19,661
-31
-0.2% -$1.15K
WMB icon
78
Williams Companies
WMB
$90.5B
$715K 0.39%
11,389
-74
-0.6% -$4.37K
SRRK icon
79
Scholar Rock
SRRK
$5.71B
$713K 0.39%
20,125
+1,917
+11% +$60.2K
SO icon
80
Southern Company
SO
$110B
$682K 0.37%
7,425
+657
+10% +$59K
AXON
81
Axon Enterprise
AXON
$40.5B
$675K 0.37%
815
-18
-2% -$12.2K
DDOG icon
82
Datadog
DDOG
$87.9B
$633K 0.34%
4,713
-1,068
-18% -$118K
EVH icon
83
Evolent Health
EVH
$475M
$620K 0.34%
55,090
+8,646
+19% +$79.4K
BBNX
84
Beta Bionics
BBNX
$706M
$620K 0.34%
42,563
+4,978
+13% +$70.5K
GBX icon
85
The Greenbrier Companies
GBX
$1.61B
$605K 0.33%
13,134
+9,007
+218% +$403K
NTNX icon
86
Nutanix
NTNX
$14.9B
$604K 0.33%
7,905
+474
+6% +$34.1K
NLY icon
87
Annaly Capital Management
NLY
$16.9B
$597K 0.33%
31,702
+440
+1% +$8.37K
CHWY icon
88
Chewy
CHWY
$8.54B
$594K 0.32%
+13,938
New +$555K
VMC icon
89
Vulcan Materials
VMC
$36.3B
$583K 0.32%
2,235
+782
+54% +$201K
MNDY icon
90
monday.com
MNDY
$3.27B
$579K 0.32%
1,840
-24
-1% -$6.68K
INSM icon
91
Insmed
INSM
$23.2B
$575K 0.31%
5,711
+474
+9% +$36.2K
KIM icon
92
Kimco Realty
KIM
$17.6B
$570K 0.31%
27,140
-222
-0.8% -$4.6K
HUBS icon
93
HubSpot
HUBS
$10.5B
$570K 0.31%
1,025
-14
-1% -$8.2K
ARGX icon
94
argenx
ARGX
$57.4B
$565K 0.31%
1,025
-14
-1% -$8.13K
GLBE icon
95
Global E Online
GLBE
$6.08B
$554K 0.3%
16,523
-2,091
-11% -$70.6K
RPRX icon
96
Royalty Pharma
RPRX
$26.1B
$554K 0.3%
15,363
-170
-1% -$5.63K
EXR icon
97
Extra Space Storage
EXR
$31.2B
$549K 0.3%
3,726
-33
-0.9% -$4.8K
COLL icon
98
Collegium Pharmaceutical
COLL
$1.14B
$546K 0.3%
18,449
+1,804
+11% +$51.5K
WDAY icon
99
Workday
WDAY
$33.4B
$545K 0.3%
2,271
-17
-0.7% -$4.14K
SHW icon
100
Sherwin-Williams
SHW
$78.3B
$539K 0.29%
1,568
-17
-1% -$5.89K

Similar funds

Values First Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Values First Advisors held 196 positions worth $184M, up 7.1% from $171M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Values First Advisors's Q2 2025 filing shows 14 new, 88 increased, 73 reduced and 15 closed positions. Its largest new stake was Rollins: 30,743 shares worth $1.73M. The largest sale was Alnylam Pharmaceuticals, an estimated $1.15M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Values First Advisors's largest Q2 2025 buy was Rollins: 30,743 shares worth $1.73M.
  • Values First Advisors added most to Microchip Technology in Q2 2025, an estimated $977K increase.
  • Values First Advisors's biggest Q2 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.15M.
  • Values First Advisors fully exited Medifast in Q2 2025, selling an estimated $869K.
  • Values First Advisors's ten largest holdings make up 28% of its $184M portfolio in Q2 2025.
  • Values First Advisors opened 14 new positions and closed 15 in Q2 2025.
  • Values First Advisors's portfolio value rose 7.1% quarter-over-quarter to $184M.

Based on Values First Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.